These data indicated that DUXAP8 could function as a scaffold by binding to EZH2 and LSD1, thus epigenetically silencing CDKN1A and KLF2 in pancreatic cancer cells. The gene discussed is DUXAP8; the disease is familial pancreatic carcinoma.